Endo International Profile

8.88
USD 0.27  2.95%
90%
82%

Bona fide gift to Michael Hyatt of 10000 shares of Endo International subject to Section 16

Endo International plc insider trading alert for gift of common stock par value $0.01 per share by Michael Hyatt, the corporate stakeholder, on June 17, 2018. This event was filed by Endo International Plc with SEC on 2013-08-09. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Endo International Summary

Endo International plc (ENDP) is traded on NASDAQ in USA. It is located in IRELAND and employs 3,039 people. Endo International is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 2.05 B. Endo International plc conducts business under Healthcare sector and is part of Drug Manufacturers - Other industry. This company has 223.79 M outstanding shares of which 37.59 M shares are currently shorted by private and institutional investors with about 7.93 trading days to cover. ENDO PHARM HLDGS currently holds about 980.41 M in cash with 435.07 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.38.
Check Endo International Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 8.88HorizonTargetOdds Above 8.88
93.61%30 days 8.88 6.35%
Based on normal probability distribution, the odds of Endo International to move above current price in 30 days from now is about 6.35% (This Endo International plc probability density function shows the probability of Endo International Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Tpg Group Holdings Sbs Advisors IncCommon Shares22.2 M131.6 M
Glenview Capital Management LlcCommon Shares21.5 M127.6 M
Ubs Group AgPut Options3 M17.5 M
View Endo International Diagnostics

Selected Endo International plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Endo International Against Markets

Risk Adjusted
Performance Score (0 to 100)
31 
Chance of
Financial Distress (0 to 100%)
29 
Equity ratings for Endo International plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Endo International operates under Drug Manufacturers - Specialty Generic classification in USA and traded on NASDAQ. It employs 30 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameEndo International plc
Special Advisor to the CEODonald DeGolyerView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
LocationIRELAND
Business AddressMinerva House
ExchangeNASDAQ
ISINUS29264F2056
CUSIPG30401106
SectorHealthcare
IndustryDrug Manufacturers - Other
BenchmarkDOW
Websitewww.endo.com
Contact Number353 1 268 2000
CurrencyUSD - US Dollar

Did you try this?

Run Focused Opportunities Now
   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Focused Opportunities

Recommendations

Endo International Analyst Recommendations
Target PriceAdvice# of Analysts
19.36Hold14Odds
Endo International plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Endo International Analyst Advice  

Earnings

Endo International Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.63February 28, 2017
Endo International plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Endo International Corporate Directors
William Spengler Director
Arthur Higgins Independent Director
William Montague Director
Additionally see Investing Opportunities. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.